세계의 동물용 피부약 시장 보고서(2025년)

Veterinary dermatology drugs are medications specifically formulated to address skin conditions in animals, such as infections, allergies, and parasites. These treatments are utilized to relieve itching, reduce inflammation, and facilitate skin healing. By addressing dermatological issues, these drugs contribute to enhancing the overall health and comfort of affected animals.

The primary categories of veterinary dermatology drugs include antifungal drugs, antibacterial drugs, and antiparasitic drugs. Antifungals are pharmaceuticals that inhibit the growth of fungi responsible for infections commonly affecting the skin, hair, and nails of animals. These drugs are administered through various routes, including topical, injectable, and oral methods. The target recipients of these medications are diverse, ranging from companion animals to livestock. The drugs are utilized for indications such as parasitic infections and allergic reactions. Distribution channels for veterinary dermatology drugs encompass retail outlets, hospital pharmacies, and online platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary dermatology drugs market research report is one of a series of new reports from The Business Research Company that provides veterinary dermatology drugs market statistics, including veterinary dermatology drugs industry global market size, regional shares, competitors with a veterinary dermatology drugs market share, detailed veterinary dermatology drugs market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary dermatology drugs industry. This veterinary dermatology drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $8.6 billion in 2024 to $9.54 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to prevalence of dermatological conditions, increased veterinary spending, changing environmental factors, companion animal healthcare awareness, regulatory approvals, zoonotic disease awareness.

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $14.71 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growing pet insurance adoption, rising incidence of allergies, globalization of pet products, holistic pet care approach, companion animal population growth, consumer education. Major trends in the forecast period include advancements in veterinary dermatology research, focus on allergy management, demand for topical treatments, nutraceuticals and dermatological health, telemedicine in veterinary dermatology, customized and personalized therapies, pet insurance and healthcare spending.

The forecast of 11.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on active pharmaceutical ingredients (APIs) used in dermatological formulations may impact production efficiency and elevate drug prices in the veterinary dermatology segment. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing number of pet owners is anticipated to boost the veterinary dermatology drugs market in the future. Pet owners are those who own or adopt animals and are responsible for their pets' health and well-being, providing necessary medical care, which in turn increases the demand for veterinary medications. For example, in 2022, Animal Medicines Australia, a non-governmental organization based in Australia, reported a significant rise in pet ownership, with the number of pet owners reaching 28,730.8, a 24% increase from 39% in 2021. This highlights a strong upward trend in pet adoption and investment in pet care, reflecting the growing popularity of pets in Australian homes. As a result, the increasing number of pet owners is driving the veterinary dermatology drugs market.

The rise in the burden of dermatological diseases is expected to contribute significantly to the growth of the veterinary dermatology drugs market. Dermatological diseases encompass a broad spectrum of medical conditions affecting the skin, influenced by factors such as genetics, environmental elements, allergies, infections, and lifestyle changes in animals. Owners, recognizing the importance of their animals' well-being, are increasingly seeking veterinary care for dermatological issues. Additionally, the awareness of zoonotic diseases, which can be transmitted between animals and humans, emphasizes the importance of managing and treating skin conditions in animals. As an example, in October 2022, a report from the British Broadcasting Corporation highlighted the impact of lumpy skin disease on over 2.4 million animals in India, leading to the death of more than 110,000 cattle. The rising burden of dermatological diseases is a significant factor driving the growth of the veterinary dermatology drugs market.

In the pursuit of sustaining their market position, major companies in the veterinary dermatology drugs market are innovating by introducing new enzyme-based healthcare solutions. For instance, in October 2022, Pet King Brands Inc., a US-based pet care company, expanded its ZYMOX Enzymatic Dermatology product line with three new offerings specifically designed for cats and kittens. These products, featuring feline-centric packaging and the Seal of Endorsement from The International Cat Association (TICA), aim to address ear and skin conditions in felines without the use of antibiotics or harsh ingredients. The ZYMOX for Cats and Kittens range includes Enzymatic Ear Solution with 0.5% Hydrocortisone, Enzymatic Ear Cleanser, and Enzymatic Topical Cream with 0.5% Hydrocortisone. Leveraging the patented LP3 Enzyme System, these products offer effective solutions for common feline conditions such as ear infections, irritated skin, hot spots, ringworm, and acne.

Major players in the veterinary dermatology drugs market are strategically forming partnerships to broaden their offerings. Strategic partnerships involve companies combining their strengths and resources to achieve mutual benefits and success. For example, in January 2022, Dechra, a UK-based specialist in veterinary pharmaceuticals and related products, entered into a partnership with Bioiberica, a life science company specializing in veterinary pharmaceuticals. The collaboration involves the licensing and distribution of the Atopivet line of dermatological products for cats and dogs in the US, aiming to enhance the health and wellbeing of humans, animals, and plants.

In January 2023, Animal Dermatology Group, Inc., a US-based veterinary dermatology firm, acquired Golden Gate Veterinary Specialists for an undisclosed sum. This acquisition is intended to enhance Animal Dermatology Group's ability to offer specialized veterinary services by integrating Golden Gate Veterinary Specialists. This move will expand their team of over 80 veterinary specialists and reinforce their commitment to providing high-quality, individualized care in dermatology, oncology, and internal medicine to meet the increasing demand for outpatient veterinary specialty services. Golden Gate Veterinary Specialists is a US-based practice specializing in dermatological and surgical care.

Major companies operating in the veterinary dermatology drugs market are Elanco Animal Health Inc., Merk & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Sante Animale, Virbac S.A., Bimeda Inc., IDEXX Laboratories Inc. SavaVet, Vetmedica, Mars Incorporated, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Veterinary Centers of America Inc., Heska Corporation, Biogenesis Bago, Nexvet, Aratana Therapeutics

North America was the largest region in the veterinary dermatology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the veterinary dermatology drugs market report forecast period. The regions covered in the veterinary dermatology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary dermatology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary dermatology drugs market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Dermatology Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary dermatology drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary dermatology drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Antifungal Drugs; Antibacterial Drugs; Antiparasitic Drugs
• 2) By Animal Type: Companion Animal; Livestock Animal
• 3) By Drug Indication: Parasitic Infections; Allergic Infections; Other Indications
• 4) By Route Of Administration: Topical; Injectable; Oral
• 5) By Distribution Channel: Retail; Hospital Pharmacies; Online
• Subsegments:
• 1) By Antifungal Drugs: Azoles; Polyenes; Allylamines; Echinocandins
• 2) By Antibacterial Drugs: Beta-lactams; Tetracyclines; Macrolides; Lincosamides; Aminoglycosides
• 3) By Antiparasitic Drugs: Insecticides; Anthelmintics; Topical Treatments; Systemic Treatments
• Companies Mentioned: Elanco Animal Health Inc.; Merk & Co. Inc.; Zoetis Inc.; Vetoquinol SA; Ceva Sante Animale; Virbac S.A.; Bimeda Inc.; IDEXX Laboratories Inc. SavaVet; Vetmedica; Mars Incorporated; Kindred Biosciences; Bayer Animal Health; Boehringer Ingelheim Vetmedica; Dechra Pharmaceuticals PLC; Norbrook Laboratories Limited; Veterinary Centers of America Inc.; Heska Corporation; Biogenesis Bago; Nexvet; Aratana Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Dermatology Drugs Market Characteristics

3. Veterinary Dermatology Drugs Market Trends And Strategies

4. Veterinary Dermatology Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Veterinary Dermatology Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Dermatology Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Dermatology Drugs Market Growth Rate Analysis
• 5.4. Global Veterinary Dermatology Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Dermatology Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Dermatology Drugs Total Addressable Market (TAM)

6. Veterinary Dermatology Drugs Market Segmentation

• 6.1. Global Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal Drugs
• Antibacterial Drugs
• Antiparasitic Drugs
• 6.2. Global Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animal
• Livestock Animal
• 6.3. Global Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parasitic Infections
• Allergic Infections
• Other Indications
• 6.4. Global Veterinary Dermatology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Injectable
• Oral
• 6.5. Global Veterinary Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail
• Hospital Pharmacies
• Online
• 6.6. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antifungal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azoles
• Polyenes
• Allylamines
• Echinocandins
• 6.7. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antibacterial Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta-lactams
• Tetracyclines
• Macrolides
• Lincosamides
• Aminoglycosides
• 6.8. Global Veterinary Dermatology Drugs Market, Sub-Segmentation Of Antiparasitic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insecticides
• Anthelmintics
• Topical Treatments
• Systemic Treatments

7. Veterinary Dermatology Drugs Market Regional And Country Analysis

• 7.1. Global Veterinary Dermatology Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Dermatology Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Dermatology Drugs Market

• 8.1. Asia-Pacific Veterinary Dermatology Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Dermatology Drugs Market

• 9.1. China Veterinary Dermatology Drugs Market Overview
• 9.2. China Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Dermatology Drugs Market

• 10.1. India Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Dermatology Drugs Market

• 11.1. Japan Veterinary Dermatology Drugs Market Overview
• 11.2. Japan Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Dermatology Drugs Market

• 12.1. Australia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Dermatology Drugs Market

• 13.1. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Dermatology Drugs Market

• 14.1. South Korea Veterinary Dermatology Drugs Market Overview
• 14.2. South Korea Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Dermatology Drugs Market

• 15.1. Western Europe Veterinary Dermatology Drugs Market Overview
• 15.2. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Dermatology Drugs Market

• 16.1. UK Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Dermatology Drugs Market

• 17.1. Germany Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Dermatology Drugs Market

• 18.1. France Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Dermatology Drugs Market

• 19.1. Italy Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Dermatology Drugs Market

• 20.1. Spain Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Dermatology Drugs Market

• 21.1. Eastern Europe Veterinary Dermatology Drugs Market Overview
• 21.2. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Dermatology Drugs Market

• 22.1. Russia Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Dermatology Drugs Market

• 23.1. North America Veterinary Dermatology Drugs Market Overview
• 23.2. North America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Dermatology Drugs Market

• 24.1. USA Veterinary Dermatology Drugs Market Overview
• 24.2. USA Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Dermatology Drugs Market

• 25.1. Canada Veterinary Dermatology Drugs Market Overview
• 25.2. Canada Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Dermatology Drugs Market

• 26.1. South America Veterinary Dermatology Drugs Market Overview
• 26.2. South America Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Dermatology Drugs Market

• 27.1. Brazil Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Dermatology Drugs Market

• 28.1. Middle East Veterinary Dermatology Drugs Market Overview
• 28.2. Middle East Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Dermatology Drugs Market

• 29.1. Africa Veterinary Dermatology Drugs Market Overview
• 29.2. Africa Veterinary Dermatology Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Dermatology Drugs Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Dermatology Drugs Market, Segmentation By Drug Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Dermatology Drugs Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Dermatology Drugs Market Competitive Landscape
• 30.2. Veterinary Dermatology Drugs Market Company Profiles
  • 30.2.1. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Vetoquinol SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Dermatology Drugs Market Other Major And Innovative Companies

• 31.1. Virbac S.A.
• 31.2. Bimeda Inc.
• 31.3. IDEXX Laboratories Inc.
• 31.4. SavaVet
• 31.5. Vetmedica
• 31.6. Mars Incorporated
• 31.7. Kindred Biosciences
• 31.8. Bayer Animal Health
• 31.9. Boehringer Ingelheim Vetmedica
• 31.10. Dechra Pharmaceuticals PLC
• 31.11. Norbrook Laboratories Limited
• 31.12. Veterinary Centers of America Inc.
• 31.13. Heska Corporation
• 31.14. Biogenesis Bago
• 31.15. Nexvet

32. Global Veterinary Dermatology Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Dermatology Drugs Market

34. Recent Developments In The Veterinary Dermatology Drugs Market

35. Veterinary Dermatology Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Dermatology Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Dermatology Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Dermatology Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer